Hi Welcome You can highlight texts in any article and it becomes audio news that you can hear
  • Mon. Nov 25th, 2024

Exclusive: Research finds concerning drop in U.S. colorectal cancer screenings and surgeries

Byindianadmin

May 28, 2020
Exclusive: Research finds concerning drop in U.S. colorectal cancer screenings and surgeries

(Reuters) – New diagnoses of one of the deadliest cancers fell by one-third in March and April as U.S. physicians and patients halted appointments and screenings during the COVID-19 outbreak.

An empty hallway is pictured in a hospital in Philadelphia , Pennsylvania, U.S. May 30, 2017. REUTERS/Carlo Allegri

Research by the health data firm Komodo Health and exclusively shared with Reuters found new colorectal cancer diagnoses declined more than 32%, while the number of performed colonoscopies and biopsies fell by nearly 90% from mid-March to mid-April, compared with the same period last year. Colorectal cancer surgeries were down by 53%.

The findings are particularly alarming because colorectal cancer is the nation’s second-leading cause of cancer deaths, according to the American Cancer Society.

Screenings have shown to be critical in curbing the disease. Since 1970, screenings helped to reduce death rates by over 50%, according to the Society. If colorectal cancer is found early, the five-year survival rate is near 90%.

The drop in surgeries suggests many patients who were newly diagnosed with colon cancer postponed procedures, enhancing their risk that the cancer could progress as the shelter-in-place orders that swept the nation in March shuttered health facilities and as patients avoided in-person appointments due to fear of contracting the virus. Medical facilities are slowly reopening, but wait times to reschedule appointments may

Read More

Click to listen highlighted text!